Freiburg University Hospital, Freiburg – Germany
About Prof. Dr. Roland Schule
Prof. Dr. Roland Schüle is a globally recognised academic Urologist and translational cancer scientist with over 29 years of experience in urology, hormone-dependent cancers, and molecular cancer research, regarded as one of the leading Urologist, Urologist and Andrologist specialists in Freiburg, Germany. He is the Scientific Director of the Department of Urology and Director of the Center for Clinical Research at the University Medical Center Freiburg.
- 29+ years of experience in urology, hormone-dependent cancer research, and translational science
- Author / co-author of 125+ scientific papers in peer-reviewed national and international journals
- Recipient of the prestigious ERC Senior Advanced Grant (2013)
- American Cancer Society California Division Senior Fellow (1991)
- Long-Term Postdoctoral Fellow of the DFG (1988)
- Scientific Director — Department of Urology & Center for Clinical Research, since 2010
Qualifications & Credentials
Medical Degrees
- Diploma in Biochemistry — University of Tübingen, Germany, 1980
- PhD in Genetics & Biochemistry — Max Planck Institute of Biochemistry, Martinsried, Germany, 1988
- Habilitation — University of Freiburg, Germany, 1997
Fellowships & Special Training
- Postdoctoral Fellow — The Salk Institute, La Jolla, USA, 1988–1991
- Long-Term Postdoctoral Fellowship — Deutsche Forschungsgemeinschaft (DFG), 1988
- American Cancer Society California Division Senior Fellowship, 1991
- Group Leader — Preclinical Research, Sandoz Ltd., Basle, Switzerland, 1991–1993
- Group Leader — Tumor Biology Center Freiburg, 1993–1999
Certifications & Accreditations
- Full Professor (W3) and Director — Center for Clinical Research, University Medical Center Freiburg, since 2005
- Scientific Director — Department of Urology, University Medical Center Freiburg, since 2010
- ERC Senior Advanced Grant Recipient — European Research Council, 2013
Areas of Expertise
Major Conditions Treated
- Prostate Cancer
- Bladder Cancer (Urothelial Carcinoma)
- Kidney Cancer
- Testicular Cancer
- Hormone-Dependent Cancers
- Andrological Disorders (Erectile Dysfunction, Male Infertility)
- Benign Prostatic Hyperplasia (BPH)
- Urinary Tract Infections (UTIs)
- Kidney Stones (Urolithiasis)
- Adrenal Disorders
Sub-specialties
- Uro-Oncology & Hormone-Dependent Cancer Research: Translational research on prostate, breast and urothelial carcinoma — sought after as a leading urologist, urologist and andrologist specialist in Freiburg, Germany for advanced uro-oncology.
- Epigenetic Therapy in Cancer: Pioneer in KMT9, LSD1 and KDM4 inhibitor research with translational application for breast and bladder cancer.
- Andrology: Diagnosis and management of male infertility, erectile dysfunction, and hormonal disorders — relevant for international patients researching the best urologist, urologist and andrologist doctor in Germany.
Advanced Procedures & Treatments
- Laparoscopic Nephrectomy
- Pyeloplasty
- Ureteric Reimplantation
- Radical Prostatectomy
- Transurethral Resection of the Prostate (TURP)
- Radical Cystectomy with Urinary Diversion
- Hormone Therapy for Prostate Cancer
- Andrological Diagnostic Workup
- Molecular Tumour Profiling for Uro-Oncology
List of Disease and Treatment for which Prof. Dr. Roland Schule can be consulted
Professional Experience
Current Affiliation
- University Medical Center Freiburg (Universitätsklinikum Freiburg), Freiburg, Germany — Full Professor (W3); Director, Center for Clinical Research; Scientific Director, Department of Urology (Present)
- Albert-Ludwigs-Universität Freiburg, Faculty of Medicine, Freiburg, Germany — Professor (Present)
Past Affiliations
- Women's Hospital, University Medical Center Freiburg, Germany — Associate Professor (C3), 1999–2004
- Tumor Biology Center Freiburg, Germany — Group Leader, 1993–1999
- Sandoz Ltd., Basle, Switzerland — Group Leader, Preclinical Research, 1991–1993
- The Salk Institute, La Jolla, USA — Postdoctoral Fellow, 1988–1991
- Max Planck Institute of Biochemistry, Martinsried, Germany — PhD Candidate (until 1988)
Academic & Research Roles
- Director, Center for Clinical Research, Medical Center — University of Freiburg (since 2005)
- Scientific Director, Department of Urology, Medical Center — University of Freiburg (since 2010)
- Investigator — CIBSS & BIOSS Clusters of Excellence, University of Freiburg
- Principal Investigator — UcarE (Urothelial Carcinoma Epigenetics) Research Unit (DFG)
Key Achievements
- 29+ years of academic urology and translational cancer research
- 125+ peer-reviewed scientific publications
- ERC Senior Advanced Grant — European Research Council, 2013
- American Cancer Society California Division Senior Fellowship, 1991
- Pioneering translational research on KMT9 / LSD1 / KDM4 inhibitors in cancer
Awards & Recognitions
National & International Awards
- ERC Senior Advanced Grant — European Research Council, 2013
- American Cancer Society California Division Senior Fellowship, 1991
- Long-Term Postdoctoral Fellowship — Deutsche Forschungsgemeinschaft (DFG), 1988
Professional Memberships
- Deutsche Gesellschaft für Urologie (German Society of Urology)
- CIBSS Cluster of Excellence — University of Freiburg
- BIOSS Cluster of Excellence — University of Freiburg
Research & Publications
Published Papers (Selected)
- Metzger E, Stepputtis SS, Strietz J, Preca BT, Urban S, Willmann D, Allen A, Zenk F, Iovino N, Bronsert P, Proske A, Follo M, Boerries M, Stickeler E, Xu J, Wallace MB, Stafford JA, Kanouni T, Maurer J, Schüle R. KDM4 inhibition targets breast cancer stem-like cells. Cancer Res. 2017;77:5900–5912.
- Duteil D, Tosic M, Willmann D, Georgiadi A, Kanouni T, Schüle R. Lsd1 prevents age-programmed loss of beige adipocytes. Proc Natl Acad Sci USA. 2017;114(20):5265–5270.
- 125+ additional peer-reviewed publications in journals including Cancer Research, PNAS, and leading urology and oncology journals.
Ongoing Research & Clinical Interests
- Targeted control of histone methyltransferase KMT9 in cancer (CID-KMT9)
- Urothelial carcinoma epigenetics (UcarE Research Unit)
- Hormone-dependent cancer biology and therapy
- Animal models and chemical tools for precision epigenome editing
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Urology / Andrology Consultation | ₹15,000 – ₹30,000 | $180 – $360 |
| Radical Prostatectomy | ₹6,00,000 – ₹15,00,000 | $7,200 – $18,000 |
| Laparoscopic Nephrectomy | ₹5,00,000 – ₹12,00,000 | $6,000 – $14,400 |
| Radical Cystectomy with Urinary Diversion | ₹8,00,000 – ₹18,00,000 | $9,600 – $21,600 |
| TURP (Prostate Surgery) | ₹2,50,000 – ₹6,00,000 | $3,000 – $7,200 |
| Andrology & Male Infertility Workup | ₹50,000 – ₹2,00,000 | $600 – $2,400 |
| Molecular Tumour Profiling (Uro-Oncology) | ₹2,50,000 – ₹6,00,000 | $3,000 – $7,200 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. Roland Schule use in Urologist, Urologist and Andrologist treatment?
Prof. Dr. Roland Schüle leverages cutting-edge translational technologies including molecular tumour profiling, epigenetic biomarkers (KMT9, LSD1, KDM4), advanced laparoscopic urology platforms, and precision oncology approaches for hormone-dependent cancers. International patients can request virtual second opinions through Cancer Rounds.
2. What conditions does Prof. Dr. Roland Schule specialize in treating?
As a leading urologist, urologist and andrologist specialist in Freiburg, Germany, Prof. Schüle works on prostate cancer, bladder cancer, kidney cancer, testicular cancer, hormone-dependent cancers, andrological disorders (male infertility, erectile dysfunction), benign prostatic hyperplasia, kidney stones, and adrenal disorders — making him one of the best urologist, urologist and andrologist doctors in Germany for advanced uro-oncology.
3. How do I book an appointment with Prof. Dr. Roland Schule?
Appointments with Prof. Dr. Roland Schule can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. Roland Schule?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. Roland Schule, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. Dr. Roland Schule offer second opinions for Urologist, Urologist and Andrologist cases?
Yes. Second opinion consultations with Prof. Dr. Roland Schule can be arranged via Cancer Rounds for patients seeking expert review of prostate, bladder or kidney cancer treatment plans from a Urologist, Urologist and Andrologist specialist in Freiburg, Germany.
